ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.547,26
-0,53%
S&P 500
5.354,60
0,03%
Dow Jones
38.953,01
0,17%
Euro vs US Dollar
1,08097
-0,75%
Bitcoin
71.059,99
0,42%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Eucrates Biomedical Acquisition Corporation (EUCRU)

  7. Eucrates Biomedical Acquisition Corporation (EUCRU) News

EUCRU

Eucrates Biomedical Acqu... (EUCRU)

Eucrates Biomedical Acquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EUCRU
DatumZeitQuelleÜberschriftSymbolFirma
26/04/202322h53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
11/04/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
03/04/202322h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
29/03/202322h41Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
16/02/202322h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
10/02/202315h44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
14/11/202223h37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
08/11/202222h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
31/10/202221h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
05/10/202223h21Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
16/05/202222h50Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
11/04/202212h04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
14/02/202220h43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
08/02/202223h17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
26/01/202222h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
20/12/202122h34Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
22/11/202122h33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
16/11/202112h05Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
16/08/202121h27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
16/07/202122h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
15/07/202123h29Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
21/06/202122h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
17/05/202113h33Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
31/03/202122h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
12/02/202122h04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
08/02/202112h02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
14/12/202023h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
14/12/202023h22PR Newswire (US)Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable WarrantsNASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
07/12/202023h26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
27/10/202021h17PR Newswire (US)Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public OfferingNASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:EUCRU

Kürzlich von Ihnen besucht

BIT
CSUS
Exchange Traded
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten